Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Alzheimer's disease (AD) pathology involves neurodegeneration in specific brain areas.
• Oligomeric amyloid-beta (Aβ) is central to AD pathogenesis, but mechanisms of neuronal loss are unclear.
• The p53 tumor suppressor protein accumulates in AD-affected brain regions, but its role is unknown.

Purpose of the Study:

• Investigate the involvement of p53 in Aβ-induced neuronal apoptosis.
• Elucidate the molecular mechanism linking Aβ exposure to neuronal death.

Main Methods:

• Exposure of cultured neurons to amyloid-beta peptides (Aβ25-35 and Aβ1-42).
• Assessed p53 protein phosphorylation, stabilization, and mitochondrial function.
• Investigated the role of cyclin-dependent kinase-5 (Cdk5) using genetic and pharmacological inhibition.
• In vivo studies in mice involving Aβ25-35 injection and p53 knockout models.

Main Results:

• Aβ25-35 exposure induced p53 phosphorylation and stabilization, causing mitochondrial dysfunction and neuronal apoptosis.
• Aβ25-35 activated Cdk5, and Cdk5 inhibition prevented p53 stabilization.
• Inhibition of p53 or Cdk5 protected neurons from Aβ-induced apoptosis, an effect replicated with full-length Aβ1-42.
• In vivo, Aβ25-35 caused p53 accumulation, dendrite disruption, and neuronal death, which were prevented in p53 knockout mice or by p53 inhibition.

Conclusions:

• Aβ triggers Cdk5 activation, leading to p53 phosphorylation and stabilization, ultimately causing neurodegeneration.
• The Cdk5-p53 pathway is a critical mediator of Aβ-induced neuronal apoptosis.
• Inhibiting the Cdk5-p53 pathway presents a potential therapeutic strategy for Alzheimer's disease.